AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC.
Insider Sentiment (TTM):
Last Purchase:-Last Sale:2026-03-02Shares Purchased (TTM):0Shares Sold (TTM):406,950
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:308,944,394Shares Outstanding:308,363,768Institutional Ownership Pct.:100.19%
Earnings Market Reaction:
Filing Date:2026-02-20Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 214 | 191 | 159 | 182 | 214 | 234 | 209 | 210 | 247 | 263 | 211 | 161 | |||||
Marketable Securities Current | 80 | 73 | 72 | 69 | 36 | 16 | 51 | 30 | 39 | 17 | 54 | 107 | |||||
Accounts Receivable Net Current | 115 | 114 | 106 | 88 | 101 | 98 | 85 | 76 | 88 | 73 | 64 | 68 | |||||
Inventory Net | 229 | 178 | 155 | 132 | 119 | 115 | 81 | 61 | 60 | 57 | 51 | 27 | |||||
Prepaid Expense And Other Assets Current | 39 | 38 | 46 | 39 | 35 | 35 | 35 | 54 | 50 | 53 | 52 | 37 | |||||
Assets Current | 676 | 594 | 538 | 511 | 505 | 498 | 462 | 431 | 483 | 463 | 433 | 400 | |||||
Operating Lease Right Of Use Asset | 21 | 22 | 22 | 22 | 22 | 23 | 23 | 23 | 26 | 30 | 28 | 28 | |||||
Property Plant And Equipment Net | 27 | 28 | 29 | 29 | 29 | 30 | 31 | 32 | 32 | 31 | 30 | 31 | |||||
Intangible Assets Net Excluding Goodwill | 14 | 15 | 16 | 16 | 17 | 18 | 19 | 20 | 20 | 21 | 22 | 23 | |||||
Goodwill | 198 | 198 | 198 | 198 | 198 | 198 | 198 | 198 | 198 | 198 | 198 | 198 | |||||
Other Assets Noncurrent | 14 | 13 | 13 | 14 | 14 | 19 | 17 | 18 | 19 | 21 | 19 | 20 | |||||
Assets | 950 | 869 | 815 | 790 | 785 | 787 | 749 | 722 | 778 | 764 | 730 | 701 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 29 | 19 | 14 | 14 | 13 | 13 | 32 | 9 | 15 | 23 | 14 | 25 | |||||
Accrued Liabilities And Other Liabilities | 200 | 171 | 145 | 130 | 127 | 136 | 128 | 125 | 144 | 139 | 125 | 93 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | 0 | 0 | 13 | 13 | |||||
Operating Lease Liability Current | 9 | 9 | 9 | 9 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | |||||
Liabilities Current | 238 | 199 | 168 | 153 | 149 | 158 | 168 | 142 | 168 | 169 | 159 | 138 | |||||
Long Term Debt | 393 | 392 | 391 | 391 | 390 | 389 | 389 | 388 | 388 | 394 | 393 | 393 | |||||
Operating Lease Liability Noncurrent | 41 | 42 | 43 | 44 | 45 | 47 | 47 | 48 | 49 | 52 | 51 | 51 | |||||
Deferred Credits And Other Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | 6 | 6 | 6 | |||||
Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | 4 | 5 | 9 | 8 | 7 | 13 | 13 | 13 | 13 | 9 | 9 | 10 | |||||
Liabilities | 676 | 638 | 611 | 596 | 591 | 608 | 617 | 591 | 618 | 631 | 619 | 598 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | 0 | - | - | - | - | - | - | - | |||||
Additional Paid In Capital Common Stock | 3,014 | 2,974 | 2,957 | 2,940 | 2,926 | 2,906 | 2,869 | 2,854 | 2,836 | 2,787 | 2,733 | 2,692 | |||||
Accumulated Other Compreh… | |||||||||||||||||
Accumulated Other Comprehensive Income Loss Foreig… | 24 | 23 | 31 | 13 | 5 | 25 | 9 | 7 | 5 | -7 | 4 | -7 | |||||
Accumulated Other Comprehensive Income Loss Availa… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Warrants And Rights Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -2,767 | -2,769 | -2,786 | -2,762 | -2,740 | -2,755 | -2,748 | -2,732 | -2,684 | -2,650 | -2,629 | -2,585 | |||||
Stockholders Equity | 274 | 230 | 204 | 194 | 194 | 179 | 133 | 131 | 160 | 133 | 112 | 103 | |||||
Liabilities And Stockholders Equity | 950 | 869 | 815 | 790 | 785 | 787 | 749 | 722 | 778 | 764 | 730 | 701 | |||||
Accumulated Depreciation Depletion And Amortizatio… | 32 | 31 | 31 | 30 | 29 | 29 | 28 | 27 | 25 | 25 | 24 | 23 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | 9 | 8 | 7 | 7 | 6 | 5 | 4 | 3 | 3 | 2 | 1 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 311 | 308 | 308 | 308 | 299 | 299 | 296 | 296 | 294 | 291 | 287 | 283 | |||||
Shares Outstanding | 311 | 308 | 308 | 308 | 299 | 299 | 296 | 296 | 294 | 291 | 287 | 283 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -6.89% | -15.57% | -10.78% | 27.05% | 39.07% | 34.22% | 10.46% | 58.51% | 58.73% | 0.21% | 0.84% | - |
| 2024 | 3.38% | 4.64% | 7.38% | 2.56% | -5.39% | 3.27% | -11.21% | -14.32% | -14.50% | -6.90% | -32.22% | -37.45% |
| 2023 | 5.09% | 8.46% | 17.18% | -6.78% | -12.27% | -22.73% | -1.23% | 24.91% | 8.63% | -10.97% | -18.07% | -26.10% |
| 2022 | - | - | - | - | - | - | - | - | - | -17.95% | -15.44% | -12.11% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.84 | 2.99 | 3.21 | 3.34 | 3.39 | 3.15 | 2.75 | 3.03 | 2.88 | 2.73 | 2.72 | 2.89 | |||||
| Quick Ratio | 1.72 | 1.90 | 2.01 | 2.22 | 2.36 | 2.20 | 2.05 | 2.22 | 2.23 | 2.09 | 2.07 | 2.42 | |||||
| Working Capital | 438.35M | 395.14M | 370.36M | 357.91M | 356.03M | 340.34M | 293.64M | 289.14M | 315.37M | 293.80M | 273.59M | 261.31M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.46 | 2.77 | 2.99 | 3.08 | 3.05 | 3.40 | 4.66 | 4.52 | 3.86 | 4.73 | 5.54 | 5.83 | |||||
| Interest Coverage TTM | 0.71 | 0.70 | 0.42 | 0.92 | 0.50 | 0.10 | -0.66 | -1.33 | -1.54 | -2.39 | -2.94 | -4.27 | |||||
| Debt Ratio | 0.71 | 0.73 | 0.75 | 0.75 | 0.75 | 0.77 | 0.82 | 0.82 | 0.79 | 0.83 | 0.85 | 0.85 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.73 | 0.72 | 0.73 | 0.72 | 0.68 | 0.64 | 0.62 | 0.60 | 0.53 | 0.49 | 0.46 | 0.44 | |||||
| Days Sales Outstanding TTM | 62.27 | 64.60 | 61.04 | 55.36 | 65.20 | 63.36 | 59.63 | 62.32 | 70.30 | 61.57 | 60.53 | 65.35 | |||||
| Receivables Turnover TTM | 5.86 | 5.65 | 5.98 | 6.59 | 5.60 | 5.76 | 6.12 | 5.86 | 5.19 | 5.93 | 6.03 | 5.59 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.09 | -0.05 | -0.12 | -0.10 | -0.18 | -0.34 | -0.39 | -0.49 | -0.51 | -0.59 | -0.63 | -0.70 | |||||
| Free Cash Flow Per Share TTM | 0.10 | 0.03 | -0.16 | 0.01 | -0.12 | -0.10 | -0.16 | -0.29 | -0.26 | -0.55 | -0.46 | -0.45 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 88.50% | 89.77% | 90.37% | 90.60% | 89.98% | 89.99% | 89.88% | 89.62% | 90.65% | 90.50% | 88.91% | 88.73% | |||||
| Operating Profit Margin TTM | 5.17% | 5.48% | 3.54% | 8.22% | 4.71% | 1.06% | -7.35% | -15.89% | -19.33% | -31.11% | -37.84% | -51.79% | |||||
| Net Profit Margin TTM | -4.27% | -2.35% | -6.67% | -5.41% | -10.62% | -21.21% | -26.23% | -34.73% | -37.96% | -46.62% | -52.86% | -60.64% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 20.05% | 21.28% | 25.35% | 28.25% | 32.29% | 32.58% | 29.98% | 25.74% | 21.30% | 15.18% | 9.16% | 5.97% | |||||
| Net Income Growth (1Y) | -51.68% | -86.57% | -68.13% | -80.03% | -62.99% | -39.70% | -35.50% | -27.99% | -35.92% | -34.24% | -34.05% | -24.37% | |||||
| EPS Growth (1Y) | -52.30% | -86.73% | -68.59% | -80.34% | -64.11% | -41.47% | -37.83% | -30.74% | -37.25% | -35.69% | -34.23% | -25.11% | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 29.85M | 9.69M | -48.91M | 1.61M | -37.44M | -31.51M | -48.10M | -88.03M | -76.53M | -161.71M | -133.56M | -131.44M | |||||
| Net Debt | 175.34M | 198.13M | 229.31M | 205.98M | 173.40M | 152.67M | 176.58M | 175.60M | 137.78M | 127.80M | 179.02M | 227.68M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2026-03-02Sale
Owner: Campbell, Bradley L
Title: President and CEO
Shares: 22,500
Price/Share: $14.35
Value: $322,875.00
Shares Owned: 998,680
Relationship: Director,Officer
Ownership: Direct
2026-01-20Sale
Owner: Campbell, Bradley L
Title: President and CEO
Shares: 75,000
Price/Share: $14.31
Value: $1,073,250.00
Shares Owned: 1,021,180
Relationship: Director,Officer
Ownership: Direct
2025-12-19Sale
Owner: Clark, David Michael
Title: Chief People Officer
Shares: 25,642
Price/Share: $14.17
Value: $363,347.14
Shares Owned: 245,690
Relationship: Officer
Ownership: Direct
2025-12-15Sale
Owner: Campbell, Bradley L
Title: President and CEO
Shares: 77,926
Price/Share: $10.86
Value: $846,276.36
Shares Owned: 1,129,782
Relationship: Director,Officer
Ownership: Direct
2025-12-15Sale
Owner: Clark, David Michael
Title: Chief People Officer
Shares: 25,643
Price/Share: $11.00
Value: $282,073.00
Shares Owned: 271,332
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
100.19%
Inst. Shares: 308,944,394
Shares Outstanding: 308,363,768
2025-12-31
102.01%
Inst. Shares: 314,564,055
Shares Outstanding: 308,363,768
2025-09-30
100.01%
Inst. Shares: 308,513,936
Shares Outstanding: 308,468,423
2025-06-30
101.61%
Inst. Shares: 313,219,162
Shares Outstanding: 308,254,256
2025-03-31
98.72%
Inst. Shares: 303,748,016
Shares Outstanding: 307,689,207
AMICUS THERAPEUTICS, INC. (FOLD) — SEC Financial Statements & Analysis
AMICUS THERAPEUTICS, INC. (FOLD) is a pharmaceutical preparations company, incorporated in DE. AMICUS THERAPEUTICS, INC. trades on Nasdaq as: FOLD. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), AMICUS THERAPEUTICS, INC. reported a 20.05% year-over-year revenue growth, a Gross Profit Margin of 88.50% (TTM), a Debt-to-Equity ratio of 2.46x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 20.05%
- Gross Profit Margin TTM
- 88.50%
- Debt To Equity
- 2.46x
Data as of 2025-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AMICUS THERAPEUTICS, INC. in?
AMICUS THERAPEUTICS, INC. (FOLD) operates in the Pharmaceutical Preparations industry.
What exchange does FOLD trade on?
AMICUS THERAPEUTICS, INC. (FOLD) trades on the Nasdaq.
Where is AMICUS THERAPEUTICS, INC. incorporated?
AMICUS THERAPEUTICS, INC. is incorporated in DE.